PRPHライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 00:56):

Stats
本日の出来高	16 599.00
平均出来高	52 045.00
時価総額	84.27M
EPS	$0 ( 2024-03-26 )
次の収益日	( $-0.280 ) 2024-05-09
Last Dividend	$0.300 ( 2022-05-24 )
Next Dividend	$0 ( N/A )
P/E	-4.77
ATR14	$0.0270 (0.58%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-17	Karkus Ted William	Buy	400 000	Option (right to buy)
2024-01-01	Latkin Jed	Buy	500 000	Option (right to buy)
2024-01-01	Latkin Jed	Buy	0
2024-03-17	Hirsch Warren	Buy	70 000	Option (right to buy)
2024-03-17	Gleckel Louis Md	Buy	70 000	Option (right to buy)

INSIDER POWER
18.17
Last 98 transactions
Buy: 8 777 863 \| Sell: 8 858 292

ボリューム相関

長: -0.26 (neutral)

短: -0.72 (moderate negative)

Signal:(35.879) Neutral

Prophase Labs Inc 相関

10 最も正の相関
RMCF	0.955
CLFD	0.955
CRON	0.939
CMRX	0.938
EVLO	0.937
BMRA	0.93
PCSA	0.929
ADP	0.928
DRUG	0.926
BFC	0.922

10 最も負の相関
GXII	-0.94
CFFE	-0.933
ARTEU	-0.933
BRIVU	-0.932
TRHC	-0.932
MSAC	-0.929
VHNA	-0.928
AMTBB	-0.927
EMLD	-0.927
ATEC	-0.926

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Prophase Labs Inc 相関 - 通貨/商品

-0.65
( moderate negative )

-0.64
( weak negative )

0.00
( neutral )

-0.62
( weak negative )

0.42
( neutral )

0.66
( moderate )

Prophase Labs Inc 財務諸表

Annual	2023
収益:	$44.38M
総利益:	$16.24M (36.59 %)
EPS:	$-0.980

FY	2023
収益:	$44.38M
総利益:	$16.24M (36.59 %)
EPS:	$-0.980

FY	2022
収益:	$122.65M
総利益:	$70.65M (57.61 %)
EPS:	$1.170

FY	2021
収益:	$79.04M
総利益:	$41.99M (53.12 %)
EPS:	$0.540

Financial Reports:

No articles found.

Prophase Labs Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Prophase Labs Inc Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	$1.000	2018-06-06
Last Dividend	$0.300	2022-05-24
Next Dividend	$0	N/A
Payout Date	2022-06-03
Next Payout Date	N/A
# dividends	6	--
Total Paid Out	$2.40	--
Avg. Dividend % Per Year	2.00%	--
Score	1.36	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-11-07)

$0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.36

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2018	$1.000	44.60%
2019	$0.500	15.40%
2020	$0	0.00%
2021	$0.300	2.84%
2022	$0.600	8.10%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.378	1.500	-7.56	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.183	1.200	-6.09	-7.30	[0 - 0.3]
returnOnEquityTTM	-0.298	1.500	-4.43	-6.64	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	2.28	0.800	3.59	2.87	[1 - 3]
quickRatioTTM	1.994	0.800	2.98	2.38	[0.8 - 2.5]
cashRatioTTM	0.103	1.500	-0.539	-0.808	[0.2 - 2]
debtRatioTTM	0.142	-1.500	7.63	-10.00	[0 - 0.6]
interestCoverageTTM	-16.95	1.000	-7.39	-7.39	[3 - 30]
operatingCashFlowPerShareTTM	-0.629	2.00	-0.210	-0.419	[0 - 30]
freeCashFlowPerShareTTM	-0.804	2.00	-0.402	-0.804	[0 - 20]
debtEquityRatioTTM	0.264	-1.500	8.94	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.366	1.000	7.24	7.24	[0.2 - 0.8]
operatingProfitMarginTTM	-0.487	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.870	1.000	-5.94	-5.94	[0.2 - 2]
assetTurnoverTTM	0.483	0.800	-0.115	-0.0916	[0.5 - 2]
Total Score				-1.795

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-5.06	1.000	-0.613	0	[1 - 100]
returnOnEquityTTM	-0.298	2.50	-2.85	-6.64	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.804	2.00	-0.268	-0.804	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.629	2.00	-0.210	-0.419	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0952	1.500	-3.97	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.256	1.000	-8.89	0	[0.1 - 0.5]
Total Score				-2.35

Prophase Labs Inc

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.